Company Overview
Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.


Opportunity Overview
Rhythm Pharmaceuticals is seeking a temporary Global Accounts Payable Accountant to join our Finance & Accounting Team for a 6 month contract. This position is responsible for working collaboratively with the Finance team and the business owners on performing the daily accounts payable activities in a SOX compliant environment.  This individual will also participate in certain general ledger activities for the monthly and quarterly financial statement close process.   This position requires the ability to multitask in a professional environment while working with people at all levels across the entire organization. A successful candidate will be a point of contact person for accounts payable, ensuring purchase order and invoice issues are resolved efficiently. They will provide these services in an effective and efficient manner, ensure that the company’s finances are accurate, and that vendors and suppliers are paid within established guidelines.

Responsibilities and Duties

• Assist with daily invoice processing of US and foreign entities through the accounting system, ensuring invoice entry and business manager invoice approvals are completed in a timely manner.
• Proper recording of value added tax (VAT) and sales tax within ERP.
• Assist with weekly payment runs (checks, ACH, & wires).
• Create, update, and manage the vendor master record in accordance with SOX.
• Assist in completing monthly and quarter-end close tasks as well as audit requests, including support for internal controls testing under SOX 404.
• Provide excellent service to our internal and external vendors by ensuring that research and resolution of AP inquiries are completed timely.
• Provide guidance to the business owners for purchase order problem solving and troubleshooting.
• Assist in quarterly training of Rhythm business owners on the procure to pay (PTP) policies and procedures including proper use of ERP.
• Assist with various aspects of Rhythm’s monthly financial close process, including preparation and posting of journal entries, reconciliation of certain balance sheet accounts and other tasks as assigned.
• Perform other duties and ad hoc projects as assigned.

• Bachelor’s degree in Finance or Accounting required.
• Minimum of two years prior experience in an Accounts Payable or a Staff Accountant role, preferably in life sciences. Experience with global payables desired.
• Understanding of Generally Accepted Accounting Principles.
• Understanding of VAT, sales tax, and 1099 reporting.
• Experience using an accounting ERP/OCR system. Microsoft Dynamics helpful.
• Prior experience in a SOX compliant environment preferred.
• Prioritization and organizational skills demonstrating the ability to meet deadlines and a strong attention to detail.
• Excellent verbal and written communication skills.
• Proficient in Microsoft Office products.

This role is based out of our corporate office in Boston, Massachusetts. Rhythm operates in a hybrid-work model. Candidates applying must be willing and able to be in the Boston office in coordination with their department and business needs. This role may involve some travel.

We are not accepting unsolicited resumes at this time. Please do not send them. 

More about Rhythm
Our lead asset, IMCIVREE® (setmelanotide), is a precision medicine designed to treat hyperphagia, an insatiable, pathological hunger characterized by abnormal food-seeking behaviors, and early- or rapid-onset severe obesity caused by an impairment of a pathway in the hypothalamus called the melanocortin-4 receptor (MC4R) pathway. IMCIVREE® is the first and only approved therapy for certain rare MC4R pathway diseases in the United States, Europe, Great Britain and several other countries. In collaboration with leading experts across the world, Rhythm is advancing the most comprehensive clinical research program ever initiated in MC4R pathway diseases, including a Phase 3 trial for acquired hypothalamic obesity. In addition, we are leveraging our extensive genetic database, global network of researchers, a track record of regulatory successes and global commercial infrastructure to develop a full portfolio of treatment options to patients struggling with hyperphagia and severe obesity and ensuring they get the treatment that is right for them.

We continue to advance care and precision medicines that address rare diseases. We are focused on expanding access to IMCIVREE® to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism. Rhythm’s headquarters is in Boston, MA.